

Can't find or afford Lokelma? Learn about alternative treatments for hyperkalemia including Veltassa, Kayexalate, and other options your doctor may consider.
If you've been prescribed Lokelma (Sodium Zirconium Cyclosilicate) for hyperkalemia but can't fill your prescription — whether it's a stock issue, an insurance denial, or the cost is too high — you need to know what alternatives exist.
The good news: Lokelma isn't the only treatment for high potassium. There are other FDA-approved medications, dietary strategies, and treatment approaches that your doctor may consider. Let's break them down so you can have an informed conversation with your healthcare provider.
Lokelma is a potassium-removing agent made by AstraZeneca. It comes as a powder that you mix with water and drink. Once in your intestines, Lokelma acts like a selective trap — it binds to potassium ions and exchanges them for hydrogen and sodium, removing the excess potassium through your stool.
Lokelma is specifically designed to treat hyperkalemia (high blood potassium levels) in adults. It's commonly prescribed for patients with chronic kidney disease (CKD), heart failure, or those taking RAAS inhibitors (like ACE inhibitors, ARBs, or spironolactone) that can raise potassium levels as a side effect.
For a deeper dive into how Lokelma works at the molecular level, check out our article on Lokelma's mechanism of action explained.
There are several reasons you might need to consider a Lokelma alternative:
Veltassa is the closest alternative to Lokelma. It's another newer-generation potassium binder that was FDA-approved in 2015 — about three years before Lokelma.
How it works: Veltassa binds to potassium in the colon and exchanges it for calcium ions. The bound potassium is then eliminated through your stool, similar to how Lokelma works but through a different ion-exchange mechanism.
Key differences from Lokelma:
Cost: Veltassa is similarly expensive, typically ranging from $800–$1,200 per month without insurance. Vifor Pharma offers a copay assistance program for commercially insured patients.
Bottom line: Veltassa is a strong alternative, especially for ongoing maintenance therapy. However, if your doctor chose Lokelma specifically for its faster onset of action, discuss whether the slower response time of Veltassa is acceptable for your situation.
Kayexalate (also known as SPS) has been the standard potassium binder since the 1950s. It's the medication your insurance company likely wants you to try first if they require step therapy before covering Lokelma.
How it works: Kayexalate is a resin that exchanges sodium for potassium in the intestines. It's available as a powder, suspension, or rectal enema.
Key differences from Lokelma:
Cost: The major advantage of Kayexalate is price. Generic SPS costs approximately $20–$60 per month, making it dramatically cheaper than both Lokelma and Veltassa.
Bottom line: Kayexalate works and it's affordable, but it comes with more side effects and safety concerns than newer options. It may be a reasonable short-term bridge while you work on getting access to Lokelma, but discuss the risks carefully with your doctor.
For patients with mild hyperkalemia, dietary changes can sometimes manage potassium levels without medication — or at least reduce the dose of potassium binder needed.
High-potassium foods to limit or avoid:
Bottom line: Dietary restriction alone is usually not enough for moderate to severe hyperkalemia, and it's not a substitute for medication if your doctor has prescribed a potassium binder. However, it's an important complementary strategy that can make your medication more effective.
Sometimes the best approach to hyperkalemia isn't adding a potassium binder — it's addressing the source. If your high potassium is being caused by a medication you're taking, your doctor may consider:
Important note: One of the main reasons doctors prescribe Lokelma is specifically to allow patients to continue taking RAAS inhibitors that are protecting their heart and kidneys. Stopping or reducing these medications isn't always the right call. This is a nuanced decision that should involve your doctor.
For patients with end-stage kidney disease (ESKD), dialysis is the most effective way to remove excess potassium from the blood. If you're already on dialysis, your nephrologist may adjust your dialysis schedule or treatment parameters to better manage potassium between sessions.
Lokelma has a specific dosing protocol for hemodialysis patients (5g to 15g on non-dialysis days), so if you're on dialysis and having trouble accessing Lokelma, talk to your nephrologist about alternative potassium management strategies between dialysis sessions.
Lokelma is an excellent medication for hyperkalemia, but it's not the only one. If you can't get it right now, don't panic — work with your doctor to choose the best alternative for your specific situation.
Before switching, try using Medfinder to locate Lokelma at a pharmacy near you. You can also check out our guide on saving money on Lokelma if cost is the primary barrier. And for a full overview of the medication, read What is Lokelma? Uses, dosage, and what you need to know.
The most important thing is that your potassium levels stay controlled. Talk to your doctor, explore your options, and don't delay treatment.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.